These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20643261)

  • 1. AJC editor's consensus: rheumatoid arthritis and atherosclerotic cardiovascular disease.
    Friedewald VE; Ganz P; Kremer JM; Mease PJ; O'Dell JR; Pearson TA; Ram CV; Ridker PM; Salmon JE; Roberts WC
    Am J Cardiol; 2010 Aug; 106(3):442-7. PubMed ID: 20643261
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.
    Sanders S; Geraci SA
    J Miss State Med Assoc; 2010 Mar; 51(3):75-80. PubMed ID: 20827876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk in rheumatoid arthritis.
    Nurmohamed MT
    Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF antagonist safety in rheumatoid arthritis: updated evidence from observational registries.
    Nasir A; Greenberg JD
    Bull NYU Hosp Jt Dis; 2007; 65(3):178-81. PubMed ID: 17922666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for cardiovascular disease in rheumatoid arthritis: defining treatment thresholds.
    Ravindran V; Hughes RA
    J Rheumatol; 2010 Jan; 37(1):200; author reply 201-2. PubMed ID: 20040642
    [No Abstract]   [Full Text] [Related]  

  • 6. [Excess mortality from cardiovascular disease in patients with rheumatoid arthritis].
    Lindhardsen J; Gislason GH; Ahlehoff O; Madsen OR; Hansen PR
    Ugeskr Laeger; 2011 Jan; 173(5):343-6. PubMed ID: 21276397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study.
    Provan SA; Semb AG; Hisdal J; Stranden E; Agewall S; Dagfinrud H; Angel K; Atar D; Kvien TK
    Ann Rheum Dis; 2011 May; 70(5):812-7. PubMed ID: 21288959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
    Kaplan MJ
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):74-5. PubMed ID: 16932633
    [No Abstract]   [Full Text] [Related]  

  • 9. New insight into rheumatoid arthritis management. The disease and the drugs used to treat it have been linked to cardiovascular disease, melanoma, and fracture.
    Duke Med Health News; 2012 Feb; 18(2):1-2. PubMed ID: 22397007
    [No Abstract]   [Full Text] [Related]  

  • 10. Editor's choice: cardiovascular disease and rheumatoid arthritis.
    Bannon M
    QJM; 2011 Jan; 104(1):1-2. PubMed ID: 21156664
    [No Abstract]   [Full Text] [Related]  

  • 11. Obesity and cardiovascular risk factors in rheumatoid arthritis.
    Armstrong DJ; McCausland EM; Quinn AD; Wright GD
    Rheumatology (Oxford); 2006 Jun; 45(6):782; author reply 782-3. PubMed ID: 16632480
    [No Abstract]   [Full Text] [Related]  

  • 12. Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis.
    Nandi P; Kingsley GH; Scott DL
    Curr Opin Rheumatol; 2008 May; 20(3):251-6. PubMed ID: 18388514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the cardiovascular disease burden in rheumatoid arthritis.
    Van Doornum S; Jennings GL; Wicks IP
    Med J Aust; 2006 Mar; 184(6):287-90. PubMed ID: 16548834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis.
    Giles JT; Post W; Blumenthal RS; Bathon JM
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):320-9. PubMed ID: 16932711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determining cardiovascular risk in patients with rheumatoid arthritis: prove the efficacy of interventions first].
    Thomas S
    Ned Tijdschr Geneeskd; 2011; 155(29):A3563. PubMed ID: 21791140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practice.
    Giles JT
    Best Pract Res Clin Rheumatol; 2015; 29(4-5):597-613. PubMed ID: 26697769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--NSAID a possible cause?].
    Pind R
    Ugeskr Laeger; 2011 Mar; 173(11):837; author reply 837. PubMed ID: 21520672
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rheumatoid arthritis (updated Current Care guideline)].
    Hakala M; Hannonen P; Helve T; Korpela M; Mattila K; Möttönen T; Varis T;
    Duodecim; 2009; 125(19):2131-2. PubMed ID: 19938416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments in rheumatoid arthritis.
    Thomas J; Scott D
    Practitioner; 2006 Jun; 250(1683):31, 33, 35 passim. PubMed ID: 16856503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.